HealthNactive

Covid 19

Education

T lymphocyte from Common colds cross-protect towards an infection with SARS-CoV-2

People with higher levels of T cells from common colds coronaviruses are less likely to become infected with SARS-CoV-2. A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells. While previous studies have shown that T cells induced by other coronaviruses

T lymphocyte from Common colds cross-protect towards an infection with SARS-CoV-2 Read More »

Omicron Vaccine Update

Omicron Vaccine Update- After three doses, serum antibodies produced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralise the SARS-CoV-2 Omicron form, according to preliminary results released by Pfizer Inc. and BioNTech SE. One month after receiving the booster immunisation (third dose of BNT162b2 vaccine), serum neutralised the Omicron variant to levels comparable to those seen after

Omicron Vaccine Update Read More »

Covid-19 Unvaccinated pregnant women Hospitalization

Unvaccinated pregnant women are increasingly being admitted to hospitals, according to new data. Expectant mothers should get their COVID-19 vaccination as soon as possible, according to England’s Chief Midwifery Officer. This comes in the wake of an alarming increase in unvaccinated women being hospitalised to hospitals with severe COVID-19, as well as indications that the

Covid-19 Unvaccinated pregnant women Hospitalization Read More »

COVID-19 Vaccines in Pregnancy & Breastfeeding

When compared to non-pregnant people, Covid-19 Vaccines in pregnancy and breastfeeding or recently pregnant women are more likely to become extremely ill with COVID-19. You can get a COVID-19 vaccine if you’re pregnant. A COVID-19 vaccine can protect you from serious COVID-19 sickness if you get it while you’re pregnant. A discussion with your healthcare

COVID-19 Vaccines in Pregnancy & Breastfeeding Read More »

2-deoxy-D-glucose, Anti-COVID drug

Anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories, Hyderabad.  It was approved for emergency use as an adjunct therapy in moderate to severe COVID-19 patients by the Drugs Controller General

2-deoxy-D-glucose, Anti-COVID drug Read More »